Alessandra M Cathel et al.
The European journal of neuroscience, 40(8), 3202-3214 (2014-08-19)
Endocannabinoids acting at the cannabinoid type 1 receptor (CB1R) are known to regulate attention, cognition and mood. Previous studies have shown that, in the rat medial prefrontal cortex (mPFC), CB1R agonists increase norepinephrine release, an effect that may be attributed